| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918164 | Radiotherapy and Oncology | 2015 | 5 Pages |
Abstract
In choosing between the two spacer technologies, the advantageous dose reduction of the balloon needs to be weighed up against the better volume consistency of the gel spacer with respect to the duration of hypofractionated vs normofractionated regimens.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Frank Wolf, Christoph Gaisberger, Ingrid Ziegler, Elisabeth Krenn, Philipp Scherer, Stephan Hruby, Tobias Schätz, Rosemarie Forstner, Josef Holzinger, Andrea Vaszi, Gerhard Kametriser, Philipp Steininger, Heinz Deutschmann, Felix Sedlmayer,